Moderna Faces Complaint To SEC Over Vax Patent Row
Oxfam America has filed a whistleblower complaint with the U.S. Securities and Exchange Commission that accuses Moderna of misleading shareholders about a fiery patent dispute over its widely distributed COVID-19 vaccine....To view the full article, register now.
Already a subscriber? Click here to view full article